Biomarkers in posttraumatic stress disorder: Overview and implications for future research

80Citations
Citations of this article
229Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

PTSD can develop in the aftermath for traumatic incidents like combat, sexual abuse, or life threatening accidents. Unfortunately, there are still no biomarkers for this debilitating anxiety disorder in clinical use. Anyhow, there are numerous studies describing potential PTSD biomarkers, some for which might progress to the point for practical use in the future. Here, we outline and comment on some for the most prominent findings on potential imaging, psychological, endocrine, and molecular PTSD biomarkers and classify them into risk, disease, and therapy markers. Since for most for these potential PTSD markers a causal role in PTSD has been demonstrated or at least postulated, this review also gives an overview on the current state for research on PTSD pathobiology. Copyright © 2013 Ulrike Schmidt et al.

Cite

CITATION STYLE

APA

Schmidt, U., Kaltwasser, S. F., & Wotjak, C. T. (2013). Biomarkers in posttraumatic stress disorder: Overview and implications for future research. Disease Markers. Hindawi Limited. https://doi.org/10.1155/2013/835876

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free